magnesium(2+)No finding here moved its endpoint.
What did not
1 findingHow to read these marks →- No detected effect on pre-eclampsia incidence
very limited
“In the analysis of all trials, oral magnesium supplementation compared to no magnesium was associated with no significant difference in perinatal mortality (stillbirth and neonatal death prior to discharge) (risk ratio (RR) 1.10; 95% confidence interval (CI) 0.72 to 1.67; five trials, 5903 infants), small-for-gestational age (RR 0.76; 95% CI 0.54 to 1.07; three trials, 1291 infants), or pre-eclampsia (RR 0.87; 95% CI 0.58 to 1.32; three trials, 1042 women).”
- Study
- meta-analysis
- Participants
- 1,042
- Effect
- 0.87 risk ratio, 95% CI 0.58 to 1.32
- Dose studied
- oral magnesium supplement, pooled forms (oxide, citrate, gluconate, aspartate, stearate) and doses
- Population
- Pregnant women in three randomised and quasi-randomised trials of oral magnesium supplementation versus placebo or no treatment
Study record
- Design
- meta-analysis
- Species
- human
- Population
- Pregnant women and their babies in 10 randomised or quasi-randomised trials of oral magnesium supplementation
- Participants
- 9,090
- Comparator
- not stated in the paper / placebo
- Duration
- not reported
- Endpoints measured
- 9
- Declined
- this platform holds no node for the endpoint